AtriCure, Inc. (ATRC)

Name: AtriCure, Inc. (ATRC) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001323885 · Nasdaq · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, AtriCure, Inc. reported revenue of $534.53M. Revenue grew 14.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $569.62M.

Key ratios (year ended 2025-12-31)

75.0%

Gross margin

-1.8%

Operating margin

-2.1%

Net margin

-2.3%

Return on year-end equity

14.9%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-24

Headquarters locality: Sharonville · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$569.62M	$534.53M	$465.31M	$399.25M	$330.38M	$274.33M	$206.53M	$230.81M	$201.63M	$174.72M	$155.11M
Cost of Revenue	$135.01M	$133.75M	$117.78M	$98.88M	$84.44M	$68.47M	$57.22M	$60.47M	$54.51M	$48.55M	$44.01M
Gross Profit	$434.61M	$400.78M	$347.52M	$300.37M	$245.94M	$205.86M	$149.31M	$170.34M	$147.12M	$126.16M	$111.10M
R&D Expense	$98.03M	$99.21M	$96.18M	$73.92M	$57.34M	$48.51M	$43.07M	$41.23M	$34.72M	$34.14M	$35.82M
Operating Income	$12.89M	-$9.45M	-$40.01M	-$26.68M	-$42.67M	$55.20M	-$44.23M	-$33.12M	-$17.13M	-$24.98M	-$31.14M
Net Income	$10.55M	-$11.45M	-$44.70M	-$30.44M	-$46.47M	$50.20M	-$48.16M	-$35.19M	-$21.14M	-$26.89M	-$33.34M
EPS (Diluted)	n/a	-$0.24	-$0.95	-$0.66	-$1.02	$1.09	-$1.14	-$0.94	n/a	n/a	n/a
Total Assets	$676.64M	$654.18M	$609.33M	$613.93M	$585.45M	$615.31M	$714.54M	$557.88M	$356.76M	$267.70M	$276.42M
Total Liabilities	$160.21M	$162.24M	$148.36M	$147.76M	$128.69M	$131.56M	$302.14M	$310.54M	$107.38M	$106.54M	$107.98M
Long-Term Debt	$61.00M	n/a	n/a	n/a	$60.00M	$60.00M	$60.00M	$60.00M	n/a	n/a	n/a
Shareholders' Equity	$516.43M	$491.94M	$460.97M	$466.17M	$456.75M	$483.76M	$412.39M	$247.34M	$249.38M	$161.17M	$168.44M
Cash & Equivalents	$167.79M	$167.43M	$122.72M	$84.31M	$58.10M	$43.65M	$41.94M	$28.48M	$32.23M	$21.81M	$24.21M
Operating Cash Flow	$64.94M	$57.33M	$12.20M	$4.48M	-$22.14M	-$13.78M	-$19.87M	-$15.81M	-$4.17M	-$8.94M	-$15.12M
Capital Expenditures	$11.82M	$9.05M	$11.46M	$12.00M	$16.88M	$9.75M	$5.26M	$12.18M	$6.21M	$6.38M	$7.69M
Free Cash Flow	$53.11M	$48.28M	$745.0K	-$7.51M	-$39.02M	-$23.53M	-$25.13M	-$27.99M	-$10.38M	-$15.33M	-$22.81M
Shares Outstanding	50.86M	49.79M	48.87M	47.53M	46.56M	46.02M	45.35M	39.66M	38.60M	34.59M	33.34M
Weighted Average Diluted Shares	n/a	47.75M	46.97M	46.31M	45.74M	46.04M	42.12M	37.59M	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.24	-$0.95	-$0.66	-$1.02	$1.11	-$1.14	-$0.94	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView